Is there a pharmacoeconomic argument supporting the use of tumor necrosis factor inhibitors in early rheumatoid arthritis?

被引：0
|
作者：
Arthur Kavanaugh
机构：
[1] Allergy,Professor of Medicine and the Director of the Center for Innovative Therapy in the Division of Rheumatology
[2] and Immunology at the University of California San Diego,undefined
来源：
Nature Clinical Practice Rheumatology | 2006年 / 2卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Tumor necrosis factor (TNF) inhibitors have proven highly effective in improving the signs and symptoms of rheumatoid arthritis, in inhibiting the progression of joint damage, and improving patients' quality of life. This Viewpoint will discuss the major concern relating to the actual use of TNF inhibitors in the clinic: their relatively high acquisition costs.
引用
收藏
页码：346 / 347
页数：1
相关论文
共 50 条
  • [21] Rheumatoid arthritis and tumor necrosis factor α
    Abe, T
    Takeuchi, T
    AUTOIMMUNITY, 2001, 34 (04) : 291 - 303
  • [22] Response of early active rheumatoid arthritis to tumor necrosis factor inhibitors: evaluation by magnetic resonance imaging
    Hirose, Wataru
    Nishikawa, Kenichiro
    Hirose, Masuko
    Nanki, Toshihiro
    Sugimoto, Hideharu
    MODERN RHEUMATOLOGY, 2009, 19 (01) : 20 - 26
  • [23] CLINICAL AND LABORATORY RESPONSE TO THE USE OF A TUMOR NECROSIS FACTOR INHIBITOR IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
    Carlos Adarmes, Juan
    Riera, Humberto
    Vera, Mariflor
    Sosa, Angel
    Escobar, Hernan
    Quintero, Maritza
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S78 - S78
  • [24] Use of tumor necrosis factor inhibitors in rheumatoid arthritis: a national survey of practicing United States rheumatologists
    Kamal, Khalid M.
    Madhavan, S. Suresh
    Hornsby, Jo Ann Allen
    Miller, Lesley-Ann
    Kavookjian, Jan
    Scott, Virginia
    JOINT BONE SPINE, 2006, 73 (06) : 718 - 724
  • [25] Use of Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Juvenile Idiopathic Arthritis or Rheumatoid Arthritis
    Lee, Wan-Ju
    Briars, Leslie
    Lee, Todd A.
    Calip, Gregory S.
    Suda, Katie J.
    Schumock, Glen T.
    PHARMACOTHERAPY, 2016, 36 (12): : 1201 - 1209
  • [26] Estimation of optimal adherence threshold for tumor necrosis factor inhibitors in rheumatoid arthritis
    Harris, Jennifer Toth
    Yang, Yi
    Bentley, John P.
    Chen, Yixin
    Ramachandran, Sujith
    CLINICAL RHEUMATOLOGY, 2024, 43 (08) : 2435 - 2444
  • [27] Effects of tumor necrosis factor-α inhibitors on lung lesions with rheumatoid arthritis
    Inoue, KI
    Takano, H
    Yanagisawa, R
    Yoshikawa, T
    CHEST, 2003, 124 (01) : 413 - 414
  • [28] The safety of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis
    Victoria Hernandez, Maria
    Sanmarti, Raimon
    Canete, Juan D.
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (05) : 613 - 624
  • [29] Predictors of tumor necrosis factor inhibitors primary failure in rheumatoid arthritis patients
    Khafagi, Amira Mohamed
    Mosa, Doaa Mosad
    Hawaas, Salah
    Hafez, Eman Abdelrazek
    EGYPTIAN RHEUMATOLOGY AND REHABILITATION, 2024, 51 (01)
  • [30] ADHERENCE EVALUATIONS FOR TUMOR NECROSIS FACTOR ALPHA INHIBITORS FOR RHEUMATOID ARTHRITIS I
    Watanabe, J. H.
    Saseen, J. J.
    Dilokthomsakul, P.
    Campbell, J. D.
    VALUE IN HEALTH, 2017, 20 (05) : A148 - A148
12345